EHR

UCL-GSK Phenomics Hub

Phenotyping at scale across diverse biobank cohorts to power genomic & proteomic analyses for target identification, drug discovery, and precision medicine.

The impact of the COVID-19 pandemic on cardiovascular disease prevention and management

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Twitter thread summarising key results

Disease Atlas

Underpinned by the needs of patients, clinicians and researchers, the Disease Atlas is an ambitious project involving the generation of a systematic, data-driven knowledge across all common and rare diseases. Using newly available nationwide data on 56 million people the Atlas is generating novel comparative insights of the health needs of patients, the care provided, and the research that is carried out.

Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19–a data-driven retrospective cohort study

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Twitter thread by Prof Ami Banerjee summarising key results

Digital ethnicity data in population-wide electronic health records in England: a description of completeness, coverage, and granularity of diversity

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } 📺 BHF Data Science Centre seminar by Dr Sara Khalid

Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } 📺 BHF Data Science Centre seminar by Dr Samantha Ip & Dr Hoda Abbasizanjani

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Twitter thread summarising key results

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Twitter thread

Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } ❗ Now published in Journal of the Royal Society of Medicine

The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale descriptive analysis of trends in medication data

❗ Now published in Nature Medicine Caroline E Dale, Rohan Takhar, Raymond Carragher, Michalis Katsoulis, Fatemeh Torabi, Stephen Duffield, Seamus Kent, Tanja Mueller, Amanj Kurdi, Stuart McTaggart, Hoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Daniel Harris, Alex Handy, Mehrdad Alizadeh Mizani, Chris Tomlinson, Johan Thygesen, Mark Ashworth, Spiros Denaxas, Amitava Banerjee, Jonathan Sterne, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Andrew Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Naveed Sattar, Reecha Sofat, CVD-COVID-UK Consortium (2023).